Vaccine Resistant Variants - Vaccines

Relevant Publications

SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity.

Issue Release: 2024

Comparative Genomics and Characterization of Shigella flexneri Isolated from Urban Wastewater.

Issue Release: 2024

Distinct Patterns of SARS-CoV-2 BA.2.87.1 and JN.1 Variants in Immune Evasion, Antigenicity and Cell-Cell Fusion.

Issue Release: 2024

Avian Orthoreoviruses: A Systematic Review of Their Distribution, Dissemination Patterns, and Genotypic Clustering.

Issue Release: 2024

A Critical Look at Heavy Ion Beam Irradiation for Vaccine Development.

Issue Release: 2024

Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium.

Issue Release: 2024

Phylogenetic Tracing of Evolutionarily Conserved Zonula Occludens Toxin Reveals a \"High Value\" Vaccine Candidate Specific for Treating Multi-Strain Infections.

Issue Release: 2024

Assessing willingness to pay for children\'s COVID-19 vaccination among healthcare providers and users using a theory-based discrete choice experiment.

Issue Release: 2024

A T cell-based SARS-CoV-2 spike protein vaccine provides protection without antibodies.

Issue Release: 2024

Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion.

Issue Release: 2024

Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmission.

Issue Release: 2024

SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?

Issue Release: 2024

Characteristics of JN.1-derived SARS-CoV-2 subvariants SLip, FLiRT, and KP.2 in neutralization escape, infectivity and membrane fusion.

Issue Release: 2024

Immunogenicity and efficacy of VLA2001 vaccine against SARS-CoV-2 infection in male cynomolgus macaques.

Issue Release: 2024

Multi-platform whole genome sequencing for tuberculosis clinical and surveillance applications.

Issue Release: 2024

Sixth monovalent XBB.1.5 vaccine elicits robust immune response against emerging SARS-CoV-2 variants in heart transplant recipients.

Issue Release: 2024

The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses.

Issue Release: 2024

Deep repertoire mining uncovers ultra-broad coronavirus neutralizing antibodies targeting multiple spike epitopes.

Issue Release: 2024

Repurposing the Open Global Health Library for the discovery of novel Mpro destabilizers with scope as broad-spectrum antivirals.

Issue Release: 2024

The nuts and bolts of recombination in the generation of SARS-CoV-2 variants; from XA to XBB.

Issue Release: 2024

What are Adjuvants?

What Should You Do If You Experience Symptoms of a Stroke Post-Vaccination?

How is Vaccine Safety Monitored?

Who Provides Vaccine Funding?

Is There a Vaccine for Hepatitis C?

What are the Future Prospects for Malaria Vaccines?

How is Vaccination Coverage Measured?

What is the Difference Between Efficacy and Effectiveness?

What are vaccines and how do they work?

Can Vaccines Trigger Autoimmune Disorders?

Partnered Content Networks

Relevant Topics